Joerg Wenzel

Sigmund Freud Str. 25
Bonn, NW 53127, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 182 publications

Editorial: Exploring innovative therapies for rare inflammatory skin diseases.

Editorial: Exploring innovative therapies for rare inflammatory skin diseases.

Journal: Frontiers in medicine

Published: March 04, 2026

Plasmacytoid dendritic cells in systemic and cutaneous lupus erythematosus: an evolving understanding.

Plasmacytoid dendritic cells in systemic and cutaneous lupus erythematosus: an evolving understanding.

Journal: Frontiers in immunology

Published: February 09, 2026

Transcriptomic crossroads: Decoding genes and pathways that connect alopecia areata with chronic inflammatory skin disorders.

Transcriptomic crossroads: Decoding genes and pathways that connect alopecia areata with chronic inflammatory skin disorders.

Journal: JID innovations : skin science from molecules to population health

Published: September 23, 2025

Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial.

Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial.

Journal: Lancet (London, England)

Published: September 18, 2025

Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trial.

Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a multicentre, international, double-blind, placebo-controlled, dose-finding phase 2 trial.

Journal: The Lancet. Rheumatology

Published: September 18, 2025

Aggressive squamous cell carcinomas arising from mucosal lichen planus: A report of three cases.

Aggressive squamous cell carcinomas arising from mucosal lichen planus: A report of three cases.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Published: July 22, 2025

Anifrolumab has a direct immunoregulatory effect on inflamed keratinocytes: implications for the treatment of lupus erythematosus skin lesions.

Anifrolumab has a direct immunoregulatory effect on inflamed keratinocytes: implications for the treatment of lupus erythematosus skin lesions.

Journal: Frontiers in immunology

Published: June 16, 2025

Enpatoran, a first-in-class, selective, orally administered toll-like receptor 7/8 inhibitor, in systemic and cutaneous lupus erythematosus: results from a randomised, placebo-controlled phase Ib study.

Enpatoran, a first-in-class, selective, orally administered toll-like receptor 7/8 inhibitor, in systemic and cutaneous lupus erythematosus: results from a randomised, placebo-controlled phase Ib study.

Journal: Lupus science & medicine

Published: June 12, 2025

The effect of belimumab on mucocutaneous and vasculitis manifestations in patients with systemic lupus erythematosus: A large pooled post hoc analysis.

The effect of belimumab on mucocutaneous and vasculitis manifestations in patients with systemic lupus erythematosus: A large pooled post hoc analysis.

Journal: Lupus

Published: May 05, 2025

Bone marrow MxA staining reflects anifrolumab response in formerly treatment-refractory systemic lupus erythematosus with initial pancytopenia.

Bone marrow MxA staining reflects anifrolumab response in formerly treatment-refractory systemic lupus erythematosus with initial pancytopenia.

Journal: Lupus

Published: April 01, 2025

Beneath the surface: delineating the subtypes of Dowling-Degos disease.

Beneath the surface: delineating the subtypes of Dowling-Degos disease.

Journal: The British journal of dermatology

Published: February 26, 2025

Cutaneous tissue samples show significant shrinkage during histopathological work-up: a real-world study.

Cutaneous tissue samples show significant shrinkage during histopathological work-up: a real-world study.

Journal: Italian journal of dermatology and venereology

Published: August 02, 2024

Showing 1-12 of 182

Last Updated: 09/26/2026